Clinical trials: Alcohol Abuse/Addiction

Cocaine Dependence, Alcohol Dependence

VIVITROL as a Treatment for Cocaine and Alcohol Dependence

• Completed
• Age: 18 to 65 years
• Phase 2
• Injection or infusion
• Results posted

To evaluate the efficacy of VIVITROL (naltrexone for extended-release injectable suspension) for the treatment of co-occurring cocaine and alcohol dependence

Trial name

NCT00777062

Testing

VIVITROL (Naltrexone extended-release injectable suspension)

Where

United States

Volunteers

80 people

Sponsor

University of Pennsylvania